Article Archive for July 2009
In April 2009 the nation received scary news; a virus was sweeping through Mexico and South America, and had reached the Southwestern United States. That virus was Swine Flu or H1N1, an influenza virus affectionately …
In the first quarter of 2009 Nanosphere, Inc. (NSPH) filed a de novo 510(k) submission for a hereditary hemochromatosis (”HFE”) genetic test. Mutations of this HFE gene are the leading cause of an iron overload disease. Nanosphere’s test …
Out of the current financial turmoil a risky trend is emerging. 401K loans which are touted as an easy and low risk way to raise some cash when times are rough are not so risk …
Saving money is one of the most difficult things to buckle down and do, yet it is also one of the most important things you can do for yourself and your family. There is nothing …
A three month extension of Transcept Pharmaceuticals’ (Nasdaq TSPT) July 30th FDA action date to October 30th is sure to cause a few more sleepless nights for the biotech company, who are working on a new …
There may be a light at the end of the tunnel for treatment failure gout (TFG) sufferers.Savient PharmaceuticalsInc. (NASDAQ SVNT) is responsible for shining that light, in the form of their ambitious drug Krystexxa. TFG …
Justin Hall a blogger from SeekingAlpha says the FDA Calendar “should be free”in a recent blog entry.
After reading this I decided to check out Justin profile, since I have never heard of him, and I …
I find it odd thatAradigm Corporation(OTC:ARDM) stock price dropped the day after Zogenix, Inc. was granted approval of the Sumavel™ DosePro. ARDM gets a $4 Million milestone payment upon first commercial sale and royalty payments …
